FX-180HDF performance evaluation

FX-180HDF performance evaluation - FX-180HDF performance evaluation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000038842

Enrollment

Registered

2019-12-23

Start date

2019-12-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End stage renal disease

Interventions

FX-180HDF, Pre-dilution 48L, under conditions of blood flow (280ml/min)for 1 week FX-180HDF, Pre-dilution 60L, under conditions of blood flow (280ml/min)for 1 week FX-180HDF, Post-dilution 12L, under

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Stable maintenance dialysis patients Patients who have no access troubles(occlusion, stenosis, etc.) or puncture difficulties Consent can be obtained from the patient or their representatives.

Exclusion criteria

Exclusion criteria: When consent from the patient or their representatives is not available for participation in this study. Any other cases that doctors consider inappropriate for participation in this study.

Design outcomes

Primary

Measure	Time frame
Concentrations of albumin, beta2-MG, alpha1-MG in dialysate drainage	—

Secondary

Measure	Time frame
Convection Volume,Transmennbrane pressure	—

Countries

Japan

Contacts

Public ContactAsako Nozaki

Kawashima Hospital Clinical department of engineering

asako.nozaki0@gmail.com088-631-0110

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026